Paclitaxel with mitoxantrone with or without 5-fluorouracil and high-dose leucovorin in the treatment of metastatic breast cancer

被引：0
|
作者：
Greco, FA
Hainsworth, JD
机构：
来源：
SEMINARS IN ONCOLOGY | 1997年 / 24卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：61 / 64
页数：4
相关论文
共 50 条
  • [21] Salvage chemotherapy in metastatic breast cancer: An experience with the combination of mitoxantrone, 5-fluorouracil, and L-leucovorin
    Colozza, M
    Gori, S
    Mosconi, AM
    Anastasi, P
    Basurto, C
    Ludovini, V
    DeAngelis, V
    Giansanti, M
    Tonato, M
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1996, 38 (03) : 277 - 282
  • [22] Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer
    Klaassen, U
    Wilke, H
    Seeber, S
    [J]. SEMINARS IN ONCOLOGY, 1996, 23 (05) : 32 - 37
  • [23] Paclitaxel/5-fluorouracil/leucovorin in metastatic breast cancer: A Vanderbilt cancer center phase II trial
    Nicholson, B
    Paul, D
    Shyr, Y
    Garrett, M
    Hande, KR
    Johnson, DH
    [J]. SEMINARS IN ONCOLOGY, 1997, 24 (04) : 20 - 23
  • [24] Irinotecan and high-dose fluorouracil/leucovorin for metastatic colorectal cancer
    Douillard, JY
    [J]. ONCOLOGY-NEW YORK, 2000, 14 (12): : 51 - 55
  • [25] A Phase II Study of Oxaliplatin, 5-Fluorouracil, Leucovorin, and High-Dose Capecitabine in Patients With Metastatic Colorectal Cancer
    Lubner, Sam J.
    LoConte, Noelle K.
    Holen, Kyle D.
    Schelman, William
    Thomas, James P.
    Jumonville, Alcee
    Eickhoff, Jens C.
    Seo, Songwon
    Mulkerin, Daniel L.
    [J]. CLINICAL COLORECTAL CANCER, 2010, 9 (03) : 157 - 161
  • [26] Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer
    M Moehler
    A Eimermacher
    J Siebler
    T Höhler
    A Wein
    M Menges
    D Flieger
    T Junginger
    T Geer
    E Gracien
    P R Galle
    M Heike
    [J]. British Journal of Cancer, 2005, 92 : 2122 - 2128
  • [27] Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer
    Moehler, M
    Eimermacher, A
    Siebler, J
    Höhler, T
    Wein, A
    Menges, M
    Flieger, D
    Junginger, T
    Geer, T
    Gracien, E
    Galle, PR
    Heike, M
    [J]. BRITISH JOURNAL OF CANCER, 2005, 92 (12) : 2122 - 2128
  • [28] Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48 hour continuous infusion in pretreated metastatic colorectal cancer
    deGramont, A
    Vignoud, J
    Tournigand, C
    Louvet, C
    Andre, T
    Varette, C
    Raymond, E
    Moreau, S
    LeBail, N
    Krulik, M
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 (02) : 214 - 219
  • [29] 5-FLUOROURACIL AND HIGH-DOSE FOLIC-ACID TREATMENT FOR METASTATIC COLON CANCER
    ASBURY, RF
    BOROS, L
    BROWER, M
    WOLL, J
    CHANG, A
    BENNETT, J
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1987, 10 (01): : 47 - 49
  • [30] A phase II Trial of Weekly Paclitaxel, 5-Fluorouracil, and Leucovorin as First-Line Treatment for Metastatic Breast Cancer
    David M. Loesch
    Lina Asmar
    Vikki A. Canfield
    Gregory A. Parker
    Harry E. Hynes
    Peter G. Ellis
    William A. Ferri
    Nicholas J. Robert
    [J]. Breast Cancer Research and Treatment, 2003, 77 : 115 - 123
12345